<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the atherogenicity of <z:chebi fb="23" ids="18059">lipids</z:chebi> in coronary patients with <z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (NFG), impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG), and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Serum <z:chebi fb="23" ids="18059">lipid</z:chebi> values, the presence of angiographic <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) at baseline, and the incidence of vascular events over 2.3 years were recorded in 750 consecutive patients undergoing coronary angiography </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:chebi fb="4" ids="17855">Triglycerides</z:chebi> significantly (P &lt; 0.001) increased and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (P &lt; 0.001) as well as <z:chebi fb="15" ids="39026">LDL</z:chebi> particle diameter (P &lt; 0.001) significantly decreased from subjects with NFG &lt;5.6 mmol/l (n = 272) over patients with IFG &gt; or =5.6 mmol/l (n = 314) to patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 164) </plain></SENT>
<SENT sid="3" pm="."><plain>Factor analysis revealed two factors in the <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles of our patients: <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A1, and <z:chebi fb="15" ids="39026">LDL</z:chebi> particle diameter loaded high on an <z:chebi fb="17" ids="39025">HDL</z:chebi>-related factor, and total cholesterol, <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B loaded high on an <z:chebi fb="15" ids="39026">LDL</z:chebi>-related factor </plain></SENT>
<SENT sid="4" pm="."><plain>In patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the <z:chebi fb="17" ids="39025">HDL</z:chebi>-related factor (odds ratio 0.648 [95% CI 0.464-0.904]; P = 0.011), but not the <z:chebi fb="15" ids="39026">LDL</z:chebi>-related factor (0.921 [0.677-1.251]; P = 0.597), was associated with significant <z:e sem="disease" ids="C0242231" disease_type="Disease or Syndrome" abbrv="">coronary stenoses</z:e> &gt; or =50% </plain></SENT>
<SENT sid="5" pm="."><plain>Consistently, in the prospective study, the <z:chebi fb="17" ids="39025">HDL</z:chebi>-related factor (0.708 [0.506-0.990]; P = 0.044), but not the <z:chebi fb="15" ids="39026">LDL</z:chebi>-related factor (1.362 [0.985-1.883]; P = 0.061), proved significantly predictive for vascular events in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo>/high <z:chebi fb="0" ids="17855">triglyceride</z:chebi> pattern is associated with the degree of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In coronary patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, this pattern correlates with the prevalence of CAD and significantly predicts the incidence of vascular events </plain></SENT>
</text></document>